An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid.
- 2024-06-26
- Clinical Trial
- Inflammopharmacology 32(4)
- Michael Thomsen
- Ravichandra Vemuri
- Flavia Huygens
- Stephen Clarke
- Luis Vitetta
- PubMed: 38926298
- DOI: 10.1007/s10787-024-01503-1
- Moderate evidence
Significant improvement in emotional QoL scores (p = 0.015) was reported with increased number of chemotherapy cycles.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes